Inventor
CAMPBELL JAMES J
US12 patents
⚠️ This page may combine multiple inventors who share the name “CAMPBELL JAMES J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
8 patentsUS11304952B2Apr 19, 2022
Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
CHEMOCENTRYX INC11 citations82
US10792360B1Oct 6, 2020
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
CHEMOCENTRYX INC6 citations82
US11020394B2Jun 1, 2021
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies
CHEMOCENTRYX INC1 citations72
US11154556B2Oct 26, 2021
Methods of treating solid tumors with CCR2 antagonists
CHEMOCENTRYX INC3 citations68
US11464786B2Oct 11, 2022
CXCR7 inhibitors for the treatment of cancer
CHEMOCENTRYX INC2 citations67
US11684606B2Jun 27, 2023
Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
CHEMOCENTRYX INC0 citations62
US11207294B2Dec 28, 2021
Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
CHEMOCENTRYX INC1 citations62
US11986466B2May 21, 2024
Methods of treating solid tumors with CCR2 antagonists
CHEMOCENTRYX INC1 citations58